nicorandil has been researched along with Acute Kidney Failure in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Fu, N; Yang, S; Zhang, P; Zhang, X | 1 |
Bellandi, F; Leoncini, M; Maioli, M; Toso, A | 1 |
El-Kashef, DH; Ezzat, DM; Soliman, AM | 1 |
Bao, H; Cheng, X; Huang, X; Jiang, L; Zhan, B | 1 |
Fu, N; Fu, X; Zeng, Z; Zhang, X | 1 |
Tian, ZL; Yao, L; Zhang, AQ; Zhang, YJ; Zhao, XX | 1 |
Kawasaki, M; Kinomura, Y; Minatoguchi, S; Nawa, T; Nishigaki, K; Tanaka, T; Yamada, Y | 1 |
Hejazi, SF; Iranirad, L; Jang, SA; Sadeghi, MS | 1 |
2 review(s) available for nicorandil and Acute Kidney Failure
Article | Year |
---|---|
Pharmacologic Prophylaxis of Contrast-Induced Nephropathy.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Angiography; Contrast Media; Europe; Female; Fluid Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Revascularization; Nicorandil; Practice Guidelines as Topic; Risk Factors; Saline Solution, Hypertonic; Trimetazidine; Vasodilator Agents | 2020 |
Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.
Topics: Acute Kidney Injury; Contrast Media; Coronary Angiography; Humans; Nicorandil; Percutaneous Coronary Intervention; Vasodilator Agents | 2018 |
4 trial(s) available for nicorandil and Acute Kidney Failure
Article | Year |
---|---|
Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Angina, Stable; Blood Urea Nitrogen; Contrast Media; Coronary Disease; Creatinine; Cystatin C; Female; Humans; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Vasodilator Agents | 2020 |
Comparison of double-dose vs. usual dose of nicorandil for the prevention of contrast-induced nephropathy after cardiac catheterization.
Topics: Acute Kidney Injury; Aged; Cardiac Catheterization; Contrast Media; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicorandil; Prospective Studies | 2019 |
Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Cystatin C; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Protective Agents; Regression Analysis; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Iran; Kidney; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Prospective Studies; Renal Agents; Risk Factors; Time Factors; Treatment Outcome | 2017 |
2 other study(ies) available for nicorandil and Acute Kidney Failure
Article | Year |
---|---|
Nicorandil mitigates folic acid-induced nephrotoxicity in mice: Role of iNOS and eNOS.
Topics: Acute Kidney Injury; Animals; Dose-Response Relationship, Drug; Folic Acid; Male; Mice; Nicorandil; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III | 2021 |
Nicorandil protects against ischaemia-reperfusion injury in newborn rat kidney.
Topics: Acute Kidney Injury; Animals; Animals, Newborn; Apoptosis; Cytokines; Disease Models, Animal; Inflammation; KATP Channels; Male; NF-kappa B; Nicorandil; Phosphatidylinositol 3-Kinases; Potassium Channels, Inwardly Rectifying; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Vasodilator Agents | 2013 |